20 Feb 2019 13:44
20 February 2019
Instem plc
("Instem")
Exercise of Options, PDMR Dealing and Total Voting Rights
Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, announces that it was notified on 19 February 2019 that certain Directors and employees of the Company, exercised share options ("Share Options") over 235,339 ordinary shares of 10 pence each in the Company ("Ordinary Shares").
Subsequently, on 19 February 2019, certain Directors sold some of the Ordinary Shares issued on the exercise of the options to finance the associated tax liabilities and for tax planning purposes.
Details of the Directors who participated in the exercise of Share Options and subsequent sale of Ordinary Shares are as follows:
Number of: | Aggregate exercise price per Ordinary Share | Resultant interest in Ordinary Shares | Resultant interest in Ordinary Shares (%) | ||
Name of Director | Share Options exercised | Ordinary Shares sold | |||
Phil Reason | 93,750 | 73,750 | 10p | 685,287 | 4.2% |
Nigel Goldsmith | 40,000 | 40,000 | 221.5p | Nil | Nil |
Further details are set out below.
Application will be made to the London Stock Exchange for the admission of the 235,339 new Ordinary Shares to trading on AIM ("New Ordinary Shares"). Admission is expected to take place at 8.00 a.m. on 26 February 2019.
Total voting rights
Following the issue and allotment of the above New Ordinary Shares, the Company's issued share capital comprises 16,153,270 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. Therefore the total number of voting rights in the Company is 16,153,270.
The figure of 16,153,270 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change of their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Phil Reason, CEO of Instem commented:
"As the Company's CEO, a major long-term shareholder and substantial holder of options over additional Ordinary Shares, I am pleased to be increasing my shareholding through the exercise of these options."
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a)
| Name
| Phil Reason | |||
2 | Reason for the notification | ||||
a)
| Position/status | Chief Executive Officer | |||
b)
| Initial notification /Amendment | Initial | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a)
| Name
| Instem plc | |||
b)
| LEI
| 213800PILYUFNNROQX68 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 10p each | |||
Identification code | GB00B3TQCK30 | ||||
b)
| Nature of the transaction | Exercise of Options | |||
c)
| Price(s) and volume(s) | ||||
Price | Volume(s) | ||||
10p (exercise price) | 93,750 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | N/A | ||||
- Price | N/A | ||||
e)
| Date of the transaction | 19 February 2019 | |||
f) | Place of the transaction | London Stock Exchange (XLON) | |||
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a)
| Name
| Phil Reason | |||
2 | Reason for the notification | ||||
a)
| Position/status | Chief Executive Officer | |||
b)
| Initial notification /Amendment | Initial | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a)
| Name
| Instem plc | |||
b)
| LEI
| 213800PILYUFNNROQX68 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 10p each | |||
Identification code | GB00B3TQCK30 | ||||
b)
| Nature of the transaction | Sale of Shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
295p | 73,750 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 73,750 | ||||
- Price | £217,562.50 | ||||
e)
| Date of the transaction | 19 February 2019 | |||
f) | Place of the transaction | London Stock Exchange (XLON) | |||
| |||||
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a)
| Name
| Nigel Goldsmith | |||
2 | Reason for the notification | ||||
a)
| Position/status | Chief Financial Officer | |||
b)
| Initial notification /Amendment | Initial | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a)
| Name
| Instem plc | |||
b)
| LEI
| 213800PILYUFNNROQX68 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 10p each | |||
Identification code | GB00B3TQCK30 | ||||
b)
| Nature of the transaction | Exercise of Options | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
221.5p (Exercise price) | 40,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | N/A | ||||
- Price | N/A | ||||
e)
| Date of the transaction | 19 February 2019 | |||
f) | Place of the transaction | London Stock Exchange (XLON) | |||
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a)
| Name
| Nigel Goldsmith | |||
2 | Reason for the notification | ||||
a)
| Position/status | Chief Financial Officer | |||
b)
| Initial notification /Amendment | Initial | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a)
| Name
| Instem plc | |||
b)
| LEI
| 213800PILYUFNNROQX68 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 10p each | |||
Identification code | GB00B3TQCK30 | ||||
b)
| Nature of the transaction | Sale of Shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
295p | 40,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 40,000 | ||||
- Price | £118,000 | ||||
e)
| Date of the transaction | 19 February 2019 | |||
f) | Place of the transaction | London Stock Exchange (XLON) | |||
For further information, please contact:
Instem plc | +44 (0) 1785 825 600 |
Phil Reason, CEO | |
Nigel Goldsmith, CFO | |
N+1 Singer (Nominated Adviser & Broker) |
+44 (0) 20 7496 3000 |
Richard Lindley Rachel Hayes | |
Walbrook Financial PR |
+44 (0) 20 7933 8780 |
Paul Cornelius | instem@walbrookpr.com |
Nick Rome Sam Allen
| |
About Instem
Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.
Instem solutions are in use by customers worldwide and enable our clients to bring life enhancing products to market faster.
Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.
Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.
To learn more about Instem solutions and its mission, please visit instem.com.